Related Experiment Videos
[Chlamydia pneumoniae infections--diagnostic methods]
Ewa Stepień1, Piotr Pieniazek, Agnieszka Branicka
1Centraine Laboratorium Kliniczne i Naukowe, Krakowski Szpital Specjalistyczny im. Jana Pawła II, Kraków. e.stepien@szpitaljp2.krakow.pl
Abstract:
Gram-negative bacteria Chlamydia pneumonia was found in 1989 to cause acute and chronic respiratory tract infections. This agent has been as well associated with other disease: atherogenesis and coronary heart disease. This study is aimed both at making an introduction to the issues related to C. pneumoniae diagnosis and presenting contemporary laboratory methods. Given the limitations of traditional diagnostics methods, serodiagnosis (EIA) and nucleic acids amplification (PCR, hybridisation) provide the most convincing evidence of C. pneumoniae infections. Culture and direct fluorescence antibody (DFA) may be useful in confirming these results. A variety of methods applied can provide an opportunity to detect bacteria in different clinical samples--incl. sputum, nasopharyngeal and throat swabs, bronchoalveolar lavage (BAL) and tissues from biopsy and autopsy.
Insights
Chlamydia pneumoniae, a bacterium causing respiratory infections, is also linked to heart disease. Modern lab methods like EIA and PCR offer reliable C. pneumoniae diagnosis, detecting the agent in various clinical samples.
Area of Science:
- Microbiology and Infectious Diseases
- Cardiovascular Research
Context:
- Chlamydia pneumoniae, identified in 1989, is a Gram-negative bacterium implicated in acute and chronic respiratory tract infections.
- Emerging evidence associates C. pneumoniae infection with atherogenesis and coronary heart disease, highlighting its broader clinical significance.
Purpose:
- To introduce diagnostic challenges and present contemporary laboratory methods for Chlamydia pneumoniae detection.
- To review advanced techniques that overcome limitations of traditional diagnostic approaches.
Summary:
- Serodiagnosis using enzyme immunoassay (EIA) and nucleic acid amplification techniques such as polymerase chain reaction (PCR) and hybridization are the most effective methods for confirming C. pneumoniae infections.
- Traditional methods like bacterial culture and direct fluorescence antibody (DFA) staining can be used as confirmatory tests.
- A range of diagnostic methods allows for the detection of C. pneumoniae in diverse clinical specimens, including sputum, swabs, bronchoalveolar lavage (BAL) fluid, and tissue samples.
Impact:
- Improved diagnostic accuracy for C. pneumoniae infections, leading to better patient management.
- Enhanced understanding of the role of C. pneumoniae in both respiratory and cardiovascular diseases.
- Facilitates the application of sensitive detection methods across a spectrum of clinical samples for etiological diagnosis.